Abstract
BackgroundRheumatoid arthritis (RA) patients with chronic hepatitis B virus infection (HBV) are at risk for HBV reactivation during TNF inhibitor (TNFi) therapy. Recent data in patients with hematologic diseases have...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
